Hot Investor Mandate 2: Venture Arm of Large Health Insurance Provider Invests Broadly in Medtech, Diagnostics, and Digital Health with Strong Strategic Value

22 Feb

A wholly-owned venture arm subsidiary of one of the largest health insurers makes strategic investments in healthcare-related innovations that will improve the quality of care and enhance the overall healthcare experience for consumers and providers. 3 important considerations are strategic value, financial return, and improvement in health outcomes. The firm typically participates in Series B or post-Series A bridge rounds. The firm entertains domestic and international opportunities.

The firm invests broadly across healthcare. Recent investments include a lung cancer diagnostics company, a specialty pharmacy company that simplifies medication management, and a behavioral health care management company. The firm expects companies to be past the proof-of-concept stage with demonstration of some traction.

The firm has no specific requirements and can work with all kinds of management teams. The firm is open to both leading and co-investing in financing rounds. The firm may take a board seat when applicable.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: